{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:40:11Z","timestamp":1789429211136,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Annexin A5 (AnxA5) is known to have anti-inflammatory and anti-apoptotic properties. Inflammation and apoptosis are key processes in post-ischemic cardiac remodeling. In this study, we investigated the effect of AnxA5 on left ventricular (LV) function and remodeling three weeks after myocardial ischemia-reperfusion (MI-R) injury in hypercholesterolemic ApoE*3-Leiden mice. Using a mouse model for MI-R injury, we demonstrate AnxA5 treatment resulted in a 27% reduction of contrast-enhanced MRI assessed infarct size (IS). End-diastolic and end-systolic volumes were decreased by 22% and 38%, respectively. LV ejection fraction was increased by 29% in the AnxA5 group compared to vehicle. Following AnxA5 treatment LV fibrous content after three weeks was reduced by 42%, which was accompanied by an increase in LV wall thickness of the infarcted area by 17%. Two days and three weeks after MI-R injury the number of cardiac macrophages was significantly reduced in both the infarct area and border zones following AnxA5 treatment compared to vehicle treatment. Finally, we found that AnxA5 stimulation leads to a reduction of IL-6 production in bone-marrow derived macrophages <jats:italic>in vitro<\/jats:italic>.\u00a0AnxA5 treatment attenuates the post-ischemic inflammatory response and ameliorates LV remodeling which improves cardiac function three weeks after MI-R injury in hypercholesterolemic ApoE*3-Leiden mice.<\/jats:p>","DOI":"10.1038\/s41598-018-25143-y","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T14:13:36Z","timestamp":1524579216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response"],"prefix":"10.1038","volume":"8","author":[{"given":"Rob C. M.","family":"de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niek J.","family":"Pluijmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-9130","authenticated-orcid":false,"given":"Margreet R.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Pettersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douwe E.","family":"Atsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6853-5760","authenticated-orcid":false,"given":"Paul H. A.","family":"Quax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"25143_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","volume":"53","author":"NG Frangogiannis","year":"2002","unstructured":"Frangogiannis, N. G., Smith, C. W. & Entman, M. L. The inflammatory response in myocardial infarction. Cardiovasc Res 53, 31\u201347 (2002).","journal-title":"Cardiovasc Res"},{"key":"25143_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","volume":"110","author":"NG Frangogiannis","year":"2012","unstructured":"Frangogiannis, N. G. Regulation of the inflammatory response in cardiac repair. Circ Res 110, 159\u2013173 (2012).","journal-title":"Circ Res"},{"key":"25143_CR3","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1161\/ATVBAHA.111.224915","volume":"32","author":"K Konstantinidis","year":"2012","unstructured":"Konstantinidis, K., Whelan, R. S. & Kitsis, R. N. Mechanisms of cell death in heart disease. Arterioscler Thromb Vasc Biol 32, 1552\u20131562 (2012).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25143_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1056\/NEJM200008103430602","volume":"343","author":"A Schomig","year":"2000","unstructured":"Schomig, A. et al. Coronary stenting plus platelet glycoprotein IIb\/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 343, 385\u2013391 (2000).","journal-title":"N Engl J Med"},{"key":"25143_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/cvr\/cvn335","volume":"81","author":"M Hori","year":"2009","unstructured":"Hori, M. & Nishida, K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 81, 457\u2013464 (2009).","journal-title":"Cardiovasc Res"},{"key":"25143_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12576-015-0365-8","volume":"65","author":"R Badalzadeh","year":"2015","unstructured":"Badalzadeh, R., Mokhtari, B. & Yavari, R. Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus. J Physiol Sci 65, 201\u2013215 (2015).","journal-title":"J Physiol Sci"},{"key":"25143_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cardiores.2003.12.023","volume":"61","author":"F Eefting","year":"2004","unstructured":"Eefting, F. et al. Role of apoptosis in reperfusion injury. Cardiovasc Res 61, 414\u2013426 (2004).","journal-title":"Cardiovasc Res"},{"key":"25143_CR8","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nri957","volume":"2","author":"J Savill","year":"2002","unstructured":"Savill, J., Dransfield, I., Gregory, C. & Haslett, C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2, 965\u2013975 (2002).","journal-title":"Nat Rev Immunol"},{"key":"25143_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.cdd.4400404","volume":"5","author":"VA Fadok","year":"1998","unstructured":"Fadok, V. A., Bratton, D. L., Frasch, S. C., Warner, M. L. & Henson, P. M. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 5, 551\u2013562 (1998).","journal-title":"Cell Death Differ"},{"key":"25143_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.bbamcr.2008.01.030","volume":"1783","author":"HO van Genderen","year":"2008","unstructured":"van Genderen, H. O., Kenis, H., Hofstra, L., Narula, J. & Reutelingsperger, C. P. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys Acta 1783, 953\u2013963 (2008).","journal-title":"Biochim Biophys Acta"},{"key":"25143_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s000180050067","volume":"53","author":"CP Reutelingsperger","year":"1997","unstructured":"Reutelingsperger, C. P. & van Heerde, W. L. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci 53, 527\u2013532 (1997).","journal-title":"Cell Mol Life Sci"},{"key":"25143_CR12","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1161\/01.CIR.96.7.2339","volume":"96","author":"P Thiagarajan","year":"1997","unstructured":"Thiagarajan, P. & Benedict, C. R. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation 96, 2339\u20132347 (1997).","journal-title":"Circulation"},{"key":"25143_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1161\/01.ATV.14.5.824","volume":"14","author":"WL van Heerde","year":"1994","unstructured":"van Heerde, W. L. et al. Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions. Arterioscler Thromb 14, 824\u2013830 (1994).","journal-title":"Arterioscler Thromb"},{"key":"25143_CR14","unstructured":"Boersma, H. H., et al Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med 46, 2035-2050, (2005)."},{"key":"25143_CR15","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/ATVBAHA.108.165522","volume":"29","author":"EM Laufer","year":"2009","unstructured":"Laufer, E. M., Winkens, M. H., Narula, J. & Hofstra, L. Molecular imaging of macrophage cell death for the assessment of plaque vulnerability. Arterioscler Thromb Vasc Biol 29, 1031\u20131038 (2009).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25143_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0300-9572(03)00034-0","volume":"57","author":"R Matsuda","year":"2003","unstructured":"Matsuda, R. et al. Clinical significance of measurement of plasma annexin V concentration of patients in the emergency room. Resuscitation 57, 171\u2013177 (2003).","journal-title":"Resuscitation"},{"key":"25143_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0140-6736(00)02482-X","volume":"356","author":"L Hofstra","year":"2000","unstructured":"Hofstra, L. et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356, 209\u2013212 (2000).","journal-title":"Lancet"},{"key":"25143_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2967\/jnumed.109.068429","volume":"51","author":"H Kenis","year":"2010","unstructured":"Kenis, H. et al. Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging. J Nucl Med 51, 259\u2013267 (2010).","journal-title":"J Nucl Med"},{"key":"25143_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1161\/ATVBAHA.110.216747","volume":"31","author":"MM Ewing","year":"2011","unstructured":"Ewing, M. M. et al. Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice. Arterioscler Thromb Vasc Biol 31, 95\u2013101 (2011).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25143_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.atherosclerosis.2012.01.037","volume":"221","author":"MM Ewing","year":"2012","unstructured":"Ewing, M. M. et al. Annexin A5 prevents post-interventional accelerated atherosclerosis development in a dose-dependent fashion in mice. Atherosclerosis 221, 333\u2013340 (2012).","journal-title":"Atherosclerosis"},{"key":"25143_CR21","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1111\/j.1755-5922.2010.00223.x","volume":"29","author":"SL Hale","year":"2011","unstructured":"Hale, S. L., Allison, A. C. & Kloner, R. A. Diannexin reduces no-reflow after reperfusion in rabbits with large ischemic myocardial risk zones. Cardiovasc Ther 29, e42\u201352 (2011).","journal-title":"Cardiovasc Ther"},{"key":"25143_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00395-012-0270-8","volume":"107","author":"MI Oerlemans","year":"2012","unstructured":"Oerlemans, M. I. et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res Cardiol 107, 270 (2012).","journal-title":"Basic Res Cardiol"},{"key":"25143_CR23","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.athoracsur.2011.02.072","volume":"91","author":"JB Velotta","year":"2011","unstructured":"Velotta, J. B. et al. P. alphaB-crystallin improves murine cardiac function and attenuates apoptosis in human endothelial cells exposed to ischemia-reperfusion. Ann Thorac Surg 91, 1907\u20131913 (2011).","journal-title":"Ann Thorac Surg"},{"key":"25143_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.109.880187","volume":"121","author":"F Arslan","year":"2010","unstructured":"Arslan, F. et al. Myocardial ischemia\/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 121, 80\u201390 (2010).","journal-title":"Circulation"},{"key":"25143_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S. D. & Frangogiannis, N. G. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res 119, 91\u2013112 (2016).","journal-title":"Circ Res"},{"key":"25143_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937\u2013952 (2004).","journal-title":"Lancet"},{"key":"25143_CR27","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1161\/01.ATV.19.11.2776","volume":"19","author":"WG Girod","year":"1999","unstructured":"Girod, W. G., Jones, S. P., Sieber, N., Aw, T. Y. & Lefer, D. J. Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 19, 2776\u20132781 (1999).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25143_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00019501-200102000-00006","volume":"12","author":"SP Jones","year":"2001","unstructured":"Jones, S. P., Girod, W. G., Marotti, K. R., Aw, T. Y. & Lefer, D. J. Acute exposure to a high cholesterol diet attenuates myocardial ischemia-reperfusion injury in cholesteryl ester transfer protein mice. Coron Artery Dis 12, 37\u201344 (2001).","journal-title":"Coron Artery Dis"},{"key":"25143_CR29","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1161\/01.CIR.103.21.2598","volume":"103","author":"R Scalia","year":"2001","unstructured":"Scalia, R. et al. Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation 103, 2598\u20132603 (2001).","journal-title":"Circulation"},{"key":"25143_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1161\/01.RES.87.3.248","volume":"87","author":"JH Lardenoye","year":"2000","unstructured":"Lardenoye, J. H. et al. Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice. Circ Res 87, 248\u2013253 (2000).","journal-title":"Circ Res"},{"key":"25143_CR31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/hrt.2007.122622","volume":"94","author":"E Wu","year":"2008","unstructured":"Wu, E. et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 94, 730\u2013736 (2008).","journal-title":"Heart"},{"key":"25143_CR32","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1160\/TH06-08-0436","volume":"97","author":"FA Kuypers","year":"2007","unstructured":"Kuypers, F. A., Larkin, S. K., Emeis, J. J. & Allison, A. C. Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity. Thromb Haemost 97, 478\u2013486 (2007).","journal-title":"Thromb Haemost"},{"key":"25143_CR33","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1538-7836.2012.04716.x","volume":"10","author":"ML Rand","year":"2012","unstructured":"Rand, M. L. et al. Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation. J Thromb Haemost 10, 1109\u20131119 (2012).","journal-title":"J Thromb Haemost"},{"key":"25143_CR34","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1161\/CIRCIMAGING.109.859678","volume":"2","author":"DE Sosnovik","year":"2009","unstructured":"Sosnovik, D. E. et al. Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia. Circ Cardiovasc Imaging 2, 460\u2013467 (2009).","journal-title":"Circ Cardiovasc Imaging"},{"key":"25143_CR35","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cardiores.2004.08.003","volume":"64","author":"V Monceau","year":"2004","unstructured":"Monceau, V. et al. Externalization of endogenous annexin A5 participates in apoptosis of rat cardiomyocytes. Cardiovasc Res 64, 496\u2013506 (2004).","journal-title":"Cardiovasc Res"},{"key":"25143_CR36","doi-asserted-by":"publisher","first-page":"H965","DOI":"10.1152\/ajpheart.01053.2005","volume":"291","author":"V Monceau","year":"2006","unstructured":"Monceau, V. et al. Myocyte apoptosis during acute myocardial infarction in rats is related to early sarcolemmal translocation of annexin A5 in border zone. Am J Physiol Heart Circ Physiol 291, H965\u2013971 (2006).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"25143_CR37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/HCO.0000000000000158","volume":"30","author":"NG Frangogiannis","year":"2015","unstructured":"Frangogiannis, N. G. Inflammation in cardiac injury, repair and regeneration. Curr Opin Cardiol 30, 240\u2013245 (2015).","journal-title":"Curr Opin Cardiol"},{"key":"25143_CR38","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1089\/ars.2006.8.1907","volume":"8","author":"NG Frangogiannis","year":"2006","unstructured":"Frangogiannis, N. G. The mechanistic basis of infarct healing. Antioxid Redox Signal 8, 1907\u20131939 (2006).","journal-title":"Antioxid Redox Signal"},{"key":"25143_CR39","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.jacc.2014.01.014","volume":"63","author":"IM Seropian","year":"2014","unstructured":"Seropian, I. M., Toldo, S., Van Tassell, B. W. & Abbate, A. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol 63, 1593\u20131603 (2014).","journal-title":"J Am Coll Cardiol"},{"key":"25143_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1161\/CIRCRESAHA.115.303567","volume":"115","author":"T Heidt","year":"2014","unstructured":"Heidt, T. et al. Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ Res 115, 284\u2013295 (2014).","journal-title":"Circ Res"},{"key":"25143_CR41","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1161\/CIRCRESAHA.114.303204","volume":"114","author":"I Hilgendorf","year":"2014","unstructured":"Hilgendorf, I. et al. Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res 114, 1611\u20131622 (2014).","journal-title":"Circ Res"},{"key":"25143_CR42","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00011-016-0931-4","volume":"65","author":"WM Jong","year":"2016","unstructured":"Jong, W. M. et al. Reduced acute myocardial ischemia-reperfusion injury in IL-6-deficient mice employing a closed-chest model. Inflamm Res 65, 489\u2013499 (2016).","journal-title":"Inflamm Res"},{"key":"25143_CR43","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0022-5223(98)70018-2","volume":"116","author":"Y Sawa","year":"1998","unstructured":"Sawa, Y., Ichikawa, H., Kagisaki, K., Ohata, T. & Matsuda, H. Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J Thorac Cardiovasc Surg 116, 511\u2013517 (1998).","journal-title":"J Thorac Cardiovasc Surg"},{"key":"25143_CR44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehy565.P2625","volume":"39","author":"M Ziegler","year":"2018","unstructured":"Ziegler, M. et al. A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia\/reperfusion injury. Eur Heart J 39, 111\u2013116 (2018).","journal-title":"Eur Heart J"},{"key":"25143_CR45","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1016\/S0021-9258(18)82232-3","volume":"268","author":"AM van den Maagdenberg","year":"1993","unstructured":"van den Maagdenberg, A. M. et al. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem 268, 10540\u201310545 (1993).","journal-title":"J Biol Chem"},{"key":"25143_CR46","first-page":"H660","volume":"277","author":"LH Michael","year":"1999","unstructured":"Michael, L. H. et al. Myocardial infarction and remodeling in mice: effect of reperfusion. Am J Physiol 277, H660\u2013668 (1999).","journal-title":"Am J Physiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25143-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25143-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25143-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:43:40Z","timestamp":1671597820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25143-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["25143"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-25143-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,30]]},"assertion":[{"value":"2 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6753"}}